日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Substandard antibiotics and their clinical outcomes among hospitalized patients in southern Malawi: a pilot study

马拉维南部住院患者中不合格抗生素及其临床结局：一项试点研究

期刊:Frontiers in Pharmacology
影响因子:4.8
doi:10.3389/fphar.2025.1535501
Chiumia, Francis Kachidza; Sinjani Muula, Adamson; Chimimba, Frider; Nyirongo, Happy Magwaza; Kampira, Elizabeth; Khuluza, Felix
发表日期：2025
文献求助 收藏

Adverse Drug Reactions Related with Antibiotic Medicines in Malawi: A Retrospective Analysis of Prevalence and Associated Factors

马拉维抗生素相关不良反应：患病率及相关因素的回顾性分析

期刊:Drug Healthcare and Patient Safety
影响因子:3.4
doi:10.2147/DHPS.S468966
Chiumia, Francis Kachidza; Chimimba, Frider; Nyirongo, Happy Magwaza; Kampira, Elizabeth Lusungu; Muula, Adamson Sinjani; Khuluza, Felix
发表日期：2024
文献求助 收藏

Impact of in-service training on the knowledge, attitude, and practice of pharmacovigilance in Malawi: a cross-sectional mixed methods study

在职培训对马拉维药物警戒知识、态度和实践的影响：一项横断面混合方法研究

期刊:Malawi Medical Journal
影响因子:0.8
doi:10.4314/mmj.v36i3.2
Chiumia, Francis; Dzabala, Nettie; Ndalama, Anderson; Sambakunsi, Cecelia; Raguenaud, Marie-Eve; Merle, Corinne; Chimimba, Frider
发表日期：2024
文献求助 收藏

Effect of antibiotic medicines availability on adherence to standard treatment guidelines among hospitalized adult patients in southern Malawi

抗生素药物可及性对马拉维南部住院成年患者遵循标准治疗指南的影响

期刊:PLoS One
影响因子:2.6
doi:10.1371/journal.pone.0293562
Chiumia, Francis Kachidza; Muula, Adamson Sinjani; Chimimba, Frider; Nyirongo, Happy Magwaza; Kampira, Elizabeth; Khuluza, Felix
发表日期：2023
文献求助 收藏

A Malawian pharmaceutical response to the COVID-19 Pandemic

马拉维应对新冠肺炎疫情的制药措施

期刊:Malawi Medical Journal
影响因子:0.8
doi:10.4314/mmj.v34i1.11
Kachingwe, Baxter; Kumpalume, Peter; Khuluza, Felix; Nyirenda, Kumbukani; Matambo, Ernest; Mponda, John; Dzabala, Nettie; Chiumia, Francis; Chikowe, Ibrahim; Chimimba, Frider; Nyoloka, Nelson; Alfazema, Louisa; Nyirongo, Happy; Smith, Dallas
肺炎
新冠
微生物学
发表日期：2022
文献求助 收藏

Human-centred design of a new microneedle-based hormonal contraceptive delivery system

以人为本的新型微针激素避孕给药系统设计

期刊:Gates Open Research
影响因子:
doi:10.12688/gatesopenres.13233.3
Gualeni, Benedetta; Hughes, Louise; Stauber, Isabelle; Ackers, Louise; Gorman, Angela; Gashuga, Dorothy; Dzabala, Nettie; Chimimba, Frider; Chikowe, Ibrahim; Coulman, Sion A; Birchall, James C
Human
免疫/内分泌
发表日期：2021
文献求助 收藏

Enhancing Pharmacovigilance in Sub-Saharan Africa Through Training and Mentoring: A GSK Pilot Initiative in Malawi

通过培训和指导加强撒哈拉以南非洲的药物警戒：葛兰素史克在马拉维的试点项目

期刊:Drug Safety
影响因子:3.8
doi:10.1007/s40264-020-00925-4
Jusot, Viviane; Chimimba, Frider; Dzabala, Nettie; Menang, Olga; Cole, Joy; Gardiner, Gregory; Ofori-Anyinam, Opokua; Oladehin, Olakunle; Sambakunsi, Cecilia; Kawaye, Mphatso; Stegmann, Jens-Ulrich; Guerra Mendoza, Yolanda
发表日期：2020
文献求助 收藏

Clinical implications for substandard, nonproprietary medicines in multiple sclerosis: focus on fingolimod

非专利劣质药物在多发性硬化症治疗中的临床意义：以芬戈莫德为例

期刊:Drug Design Development and Therapy
影响因子:5.1
doi:10.2147/DDDT.S106802
Correale, Jorge; Chiquete, Erwin; Boyko, Alexey; Beran, Roy G; Strauch, Jorge Barahona; Milojevic, Snezana; Frider, Nadina
神经科学
多发性硬化症
发表日期：2016
文献求助 收藏

Safety and Tolerability of Fingolimod in Latin American Patients with Relapsing-Remitting Multiple Sclerosis: The Open-Label FIRST LATAM Study

芬戈莫德在拉丁美洲复发缓解型多发性硬化症患者中的安全性和耐受性：开放标签的 FIRST LATAM 研究

期刊:Advances in Therapy
影响因子:4
doi:10.1007/s12325-015-0224-2
Ordoñez-Boschetti, Laura; Rey, Roberto; Cruz, Ana; Sinha, Arijit; Reynolds, Tracy; Frider, Nadina; Alvarenga, Regina
神经科学
LAT
多发性硬化症
发表日期：2015
文献求助 收藏

Erratum to: Safety and Tolerability of Fingolimod in Latin American Patients with Relapsing-Remitting Multiple Sclerosis: The Open-Label FIRST LATAM Study

更正：芬戈莫德在拉丁美洲复发缓解型多发性硬化症患者中的安全性和耐受性：开放标签 FIRST LATAM 研究

期刊:Advances in Therapy
影响因子:4
doi:10.1007/s12325-015-0230-4
Ordoñez-Boschetti, Laura; Rey, Roberto; Cruz, Ana; Sinha, Arijit; Reynolds, Tracy; Frider, Nadina; Alvarenga, Regina
神经科学
LAT
多发性硬化症
发表日期：2015
文献求助 收藏